BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12547709)

  • 1. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma.
    Miura M; El-Sawy T; Fairchild RL
    Am J Pathol; 2003 Feb; 162(2):509-19. PubMed ID: 12547709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients.
    Lendermon EA; Dodd-o JM; Coon TA; Miller HL; Ganguly S; Popescu I; O'Donnell CP; Cardenes N; Levine M; Rojas M; Weathington NM; Zhao J; Zhao Y; McDyer JF
    Am J Respir Cell Mol Biol; 2015 May; 52(5):622-33. PubMed ID: 25286244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.
    Morita K; Miura M; Paolone DR; Engeman TM; Kapoor A; Remick DG; Fairchild RL
    J Immunol; 2001 Sep; 167(5):2979-84. PubMed ID: 11509648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
    Zhang QW; Kish DD; Fairchild RL
    J Immunol; 2003 Jun; 170(11):5530-7. PubMed ID: 12759430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
    Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
    J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-5 and eosinophils mediate the rejection of fully histoincompatible vascularized cardiac allografts: regulatory role of alloreactive CD8(+) T lymphocytes and IFN-gamma.
    Braun MY; Desalle F; Le Moine A; Pretolani M; Matthys P; Kiss R; Goldman M
    Eur J Immunol; 2000 May; 30(5):1290-6. PubMed ID: 10820374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
    Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
    J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac Allografts.
    Iida S; Tsuda H; Tanaka T; Kish DD; Abe T; Su CA; Abe R; Tanabe K; Valujskikh A; Baldwin WM; Fairchild RL
    J Immunol; 2016 Mar; 196(6):2827-37. PubMed ID: 26856697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection.
    Miura M; Morita K; Kobayashi H; Hamilton TA; Burdick MD; Strieter RM; Fairchild RL
    J Immunol; 2001 Sep; 167(6):3494-504. PubMed ID: 11544343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig.
    Koga S; Auerbach MB; Engeman TM; Novick AC; Toma H; Fairchild RL
    J Immunol; 1999 Nov; 163(9):4878-85. PubMed ID: 10528189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma alters the pathology of graft rejection: protection from early necrosis.
    Halloran PF; Miller LW; Urmson J; Ramassar V; Zhu LF; Kneteman NM; Solez K; Afrouzian M
    J Immunol; 2001 Jun; 166(12):7072-81. PubMed ID: 11390451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor IFN-gamma receptors are critical for acute CD4(+) T cell-mediated cardiac allograft rejection.
    Wiseman AC; Pietra BA; Kelly BP; Rayat GR; Rizeq M; Gill RG
    J Immunol; 2001 Nov; 167(9):5457-63. PubMed ID: 11673565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.
    El-Sawy T; Miura M; Fairchild R
    Am J Pathol; 2004 Jul; 165(1):147-57. PubMed ID: 15215170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated rejection of single class I MHC-disparate cardiac allografts.
    Hattori Y; Bucy RP; Kubota Y; Baldwin WM; Fairchild RL
    Am J Transplant; 2012 Aug; 12(8):2017-28. PubMed ID: 22578247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
    Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
    Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
    Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
    Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic antagonism of Mig inhibits cellular infiltration and promotes survival of class II MHC disparate skin allografts.
    Kobayashi H; Novick AC; Toma H; Fairchild RL
    Transplantation; 2002 Aug; 74(3):387-95. PubMed ID: 12177619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.